This is the authors' abstract. We don't add key points for this paper.
Bruno M. Camargosa, Rubens L. C. Tavaresa*, Helen L. Del Puertoa, Luciana O. Andradeb, Aroldo F. Camargosa & Fernando M. Reisaa Department of Obstetrics and Gynecology and b Department of Morphology, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil*These authors contributed equally to this work.Correspondence: Rubens Lene Carvalho Tavares, Department of Obstetrics and Gynecology, Hospital das Clínicas, Federal University of Minas Gerais, Av. Alfredo Balena 110 - 9o andar, Belo Horizonte, MG 30130-100, Brazil. Tel: +5531 3409 9485. Fax: +5531 3409 9299. E-mail: rubens.ufmg@gmail.comAbstractActivin A is a growth factor released by mature osteoblasts that has a critical effect on bone formation. We investigated the effect of bone morphogenetic protein (BMP)-4 on activin A gene expression during in vitro osteogenic differentiation of mouse embryonic stem (ES) cells. Embryoid bodies were cultured in retinoic acid (RA) for three days and then without RA for two days. Seeded cells received osteogenic medium with β-glycerophosphate, L-ascorbic acid 2-phosphate and dexamethasone during 19 days, with or without BMP-4. Six independent experiments were carried out. Real-time PCR was used to detect gene expression of activin A, Oct-4, Nanog, osteocalcin, RUNX2 and bone alkaline phosphatase. Immunofluorescence was used to co-localize activin A with the undifferentiation marker stage-specific embryonic antigen 1. Cells treated with BMP-4 had an increased gene expression of activin A, osteocalcin and bone alkaline phosphatase (p < 0.05). In conclusion, BMP-4 increases activin A gene expression during mouse ES cell differentiation into bone precursors.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Camargos et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: